Gastroesophageal Reflux Disease Devices Market is poised to value over CAGR of over 13.5% during the forecast period 2022 to 2028.

GERD is a disorder in which the lower esophageal sphincter (LES) relaxes or fails to function properly, allowing stomach liquids to reflux back into the oesophagus and cause heartburn. GERD is caused by a number of causes including smoking, hiatal hernia, abdominal obesity, and stress. GERD can cause esophagitis (swelling of the oesophagus), Barrett's oesophagus (barrel disease), and ulcers if left untreated. The severity of the condition is used to create treatment modules. In many countries, increased rates of abdominal obesity, as well as unhealthy diets and lifestyles, are linked to an increase in the prevalence of GERD. The demand for gastroesophageal reflux disease devices will rise as a result of this. The prevalence of gastroesophageal reflux is not gender-specific; nevertheless, males are more likely to develop problems as a result of the disease. GERD is more common as people get older, especially after the age of 40. The difficulties related with esophageal motility and a decreased production of saliva are linked to esophageal dysfunction in the older population. As a result, the growing senior population will continue to drive the market for gastroesophageal reflux disease devices. One of the primary factors driving market expansion is the high rate of obesity in the United States.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Gastroesophageal Reflux Disease Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Gastroesophageal Reflux Disease Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Gastroesophageal Reflux Disease Devices Market:
• Addex Pharmaceuticals Ltd.
• Aros Pharma ApS
• AstraZeneca Plc.
• C. R. Bard, Inc.
• Eisai Co., Ltd.
• EndoGastric Solutions, Inc.
• MediGus Ltd.
• Olympus Corporation
• PENTAX Medical (Global)
• Pfizer Inc.
• Takeda Pharmaceutical Company Limited
• The Procter & Gamble Company
(Note: The list of the major players will be updated with the latest market scenario and trends)

Gastroesophageal Reflux Disease Devices Market Segmentation:
By Product Type
• Diagnostic Devices
• Esophagoscopes and Gastroscopes
• Fundoplication Devices
• Manometry System
• PH Monitoring System
• Radiofrequency Ablation Devices
• Sphincter Augmentation Devices
• Treatment Devices
• Ultrasonic Surgical Endostapler
By Procedure Type
• Diagnostic Procedures
• Fundoplication Procedures
• Magnetic Sphincter Augmentation
• Radiofrequency Thermal Ablation
By Device Type
• Bravo Reflux Testing System
• Digitrapper reflux testing system
• LINX Management System
• MUSE -Medigus Ultrasonic Surgical Endostapler
• Others
• Stretta Therapy
By Surgery Type
• Invasive
 o Linx Reflux Management
 o Medigus Ultrasonic Surgical Endostapler
• Non-invasive
 o Endocinch Endolumminal gastroplication
 o Endoscopic Plicator System
 o EsophyX
 o Plexiglas poly-methyl-methacrylate (PMMA) microspheres
 o Stretta
By Route of Administration
• Oral
• Parenteral
By Dosage Form
• Liquid
• Solid
By End Users
• Government
• Hospitals
• Medical Practitioners
• Others
By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Gastroesophageal Reflux Disease Devices Market By Product Type, By Procedure Type, By Device Type, By Surgery Type, By Route of Administration, By Dosage Form, By End Users and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics